Skip to content
Clinical Trials – home
LatviaBack to Latvia

Clinical trials in Talsi – page 2

15 clinical trials in Talsi, Latvia. Every trial is listed in the EU Clinical Trials Register and updated daily.

LatviaOur site in LatviaKliniskiePetijumi.lv(opens in a new tab)
Talsi at a glance
15
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

15 trials in Talsi

Open in trial search

Hypertriglyceridaemia

Not recruiting

Study on Plozasiran and ARO-APOC3 for Adults with Severe Hypertriglyceridemia

Investigational
Countries:LatviaLatvia
  • Participants:18–64 years · 65+ years
  • Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
  • Sponsor:Arrowhead Pharmaceuticals Inc.

Study on the Effectiveness and Safety of Gliclazide MR, Dapagliflozin, and Metformin for Patients with Type 2 Diabetes Not Well Controlled with Dapagliflozin

Registered drug
Countries:LatviaLatvia
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin
  • Sponsor:Institut De Recherches Internationales Servier IRIS

Atrial fibrillation+2

Not recruiting

Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

Registered drug
Countries:LatviaLatvia
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Bayer AG

Other cities in Latvia

The busiest research cities in the country

All 18 cities in Latvia

Clinical research in Talsi

What the registry says about research in the country

01 Dermatology Research

Multiple clinical trials focusing on plaque psoriasis treatments are evaluating novel therapeutic approaches. Studies are examining both long-term safety and immediate efficacy of innovative medications for patients with moderate to severe conditions.

  • ESK-001 Safety Studies
  • TAK-279 Long-term Evaluation
  • Comparative Treatment Analysis

These investigations aim to expand treatment options for patients with challenging dermatological conditions.

02 Inflammatory Skin Conditions

Research initiatives are exploring treatments for atopic dermatitis, with particular attention to long-term therapeutic solutions. The studies include assessment of nemolizumab in both adult and adolescent populations.

  • Adolescent Treatment Options
  • Long-term Safety Protocols
  • Moderate-to-Severe Cases

These trials represent significant advancement in understanding chronic skin condition management.

03 Therapeutic Innovations

Current clinical research is evaluating multiple treatment modalities for chronic skin conditions, including both oral medications and specialized therapies. Studies focus on measuring both immediate and sustained therapeutic responses.

  • Novel Drug Development
  • Safety Monitoring
  • Treatment Durability

Research aims to establish more effective and sustainable treatment options for patients with persistent skin disorders.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.